Anya J. Burton, Kate M. Tilling, Jeff M. Holly, Freddie C. Hamdy, Mari-Anne E. Rowlands, Jenny L. Donovan, Richard M. Martin: Metabolic imbalance and prostate cancer progression. Int J Mol Epidemiol Genet 2010;1(4):248-271. (Full text, PDF)
Kathryn L Terry, Allison F Vitonis, Dena Hernandez, Galina Lurie, Honglin Song, Susan J Ramus, Linda Titus-Ernstoff, Michael E Carney, Lynne R Wilkens, Aleksandra Gentry-Maharaj, Usha Menon, Simon A Gayther, Paul D Pharaoh, Marc T Goodman, Daniel W Cramer, and Michael J Birrer on behalf of the Ovarian Cancer Association Consortium: A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies. Int J Mol Epidemiol Genet 2010;1(4):272-277. (Full text, PDF)
Nataliya Kuptsova-Clarkson, Christine B. Ambrosone, Joli Weiss, Maria R. Baer, Lara E. Sucheston, Gary Zirpoli, Kenneth J. Kopecky, Laurie Ford, Javier Blanco, Meir Wetzler5, Kirsten B. Moysich: XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia. Int J Mol Epidemiol Genet 2010;1(4):278-294. (Full text, PDF)
Timothy R. Church, Majda Haznadar, Mindy S. Geisser, Kristin E. Anderson, Neil E. Caporaso, Chap Le, Salwan B.Abdullah, Stephen S. Hecht, Martin M. Oken, Brian Van Ness: Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk. Int J Mol Epidemiol Genet 2010;1(4):295-309. (Full text, PDF)
Nicolas von Ahsen, Mladen Tzvetkov, Harin A Karunajeewa, Servina Gomorrai, Alice Ura, Jürgen Brockmöller, Timothy ME Davis, Ivo Mueller, Kenneth F Ilett, Michael Oellerich: CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess. Int J Mol Epidemiol Genet 2010;1(4):310-319. (Full text, PDF)
Simone P. Pinheiro, Margaret A. Gates, Immaculata DeVivo, Bernard A. Rosner, Shelley S. Tworoger, Linda Titus-Ernstoff, Susan E. Hankinson, Daniel W. Cramer: Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk. Int J Mol Epidemiol Genet 2010;1(4):320-331. (Full text, PDF)
Barbara K. Dunn, Mark H. Greene, Jenny M. Kelley, Joseph P. Costantino, Robert J. Clifford, Ying Hu, Gong Tang, Neely Kazerouni, Philip S. Rosenberg, Daoud M. Meerzaman, Kenneth H. Buetow: Novel pathway analysis of genomic polymorphism-cancer risk interaction in the breast cancer prevention trial. Int J Mol Epidemiol Genet 2010;1(4):332-349. (Full text, PDF)
Yi Ye, Van Zyl Berendine, Charlotte Hellmich, Kathleen M. Gillespie: Microchimerism: covert genetics? Int J Mol Epidemiol Genet 2010;1(4):350-357. (Full text, PDF)
Tian Tian, Yan Xu, Juncheng Dai, JinChang Wu, Hongbing Shen, Zhibin Hu: Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis. Int J Mol Epidemiol Genet 2010;1(4):358-366. (Full text, PDF)
Krati Chauhan, Richard B. Devereux, D.C. Rao, Ulrich Broeckel, Charles C. Gu, Paul Hopkins, Donna K. Arnett: Adducin 1 (alpha) Gly460Trp variant is associated with left ventricular geometry in Caucasians and African Americans: The HyperGEN Study. Int J Mol Epidemiol Genet 2010;1(4):367-376. (Full text, PDF)
